PAB 0.00% 0.4¢ patrys limited

Ann: Patrys Investor Presentation - September 2014, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,670 Posts.
    Free speech is different to accusing someone of working for a company and having a hidden agenda.
    Anyway lets stay on topic.


    I have been pretty disappointed with the communication from management and performance of the stock.
    If we can hit these milestones by the end of this year as stated than we should see the share price steadily increasing again.



    Key Milestone Projected Timing
    (CY)
    PAT-SM6:
    o Final data from monotherapy MM trial
    o Complete GMP manufacturing for combination MM trial
    o Commence combination Phase Ib/IIa MM trial
    o Preclinical and clinical data published
    1Q, 2014
    2H, 2014
    4Q, 2014
    4Q, 2014

    PAT-LM1:
    o Complete manufacturing process development ready for scale-up
    o Preclinical data published
    2H, 2014
    2H, 2014
    PAT-SC1:
    o Preclinical & clinical trial (gastric cancer) data published
    o Out-licensing deal
    1Q, 2014
    2014

    Discovery Abs:
    o Target work on PAT-SM3, PAT-SM4, PAT-H12 2014
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.229M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $3.117K 1.013M

Buyers (Bids)

No. Vol. Price($)
39 44343144 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 10764841 13
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.